Additionally, the disease activity index [DAI] showed a trend towards improvement in ESM-HDAC528-treated mice [ Figure 6E ] and a reduced colon inflammation histological score was noted after ESM-HDAC528 as compared with controls [ Figure 6F ].
← all excerpts
Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease.
1
—
—